Hixon Zuercher’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
30,731
+226
| +0.7% | +$17.7K | 0.78% | 48 |
|
|
2025
Q1 | $2.21M | Buy |
30,505
+5,421
| +22% | +$393K | 0.78% | 49 |
|
|
2024
Q4 | $1.86M | Sell |
25,084
-2,533
| -9% | -$188K | 0.71% | 50 |
|
|
2024
Q3 | $1.82M | Buy |
27,617
+312
| +1% | +$20.6K | 0.71% | 52 |
|
|
2024
Q2 | $2.52M | Buy |
27,305
+676
| +3% | +$62.4K | 1.06% | 35 |
|
|
2024
Q1 | $2.54M | Buy |
26,629
+1,086
| +4% | +$104K | 1.08% | 37 |
|
|
2023
Q4 | $1.95M | Buy |
25,543
+559
| +2% | +$42.6K | 0.9% | 41 |
|
|
2023
Q3 | $1.73M | Buy |
24,984
+1,747
| +8% | +$121K | 0.91% | 40 |
|
|
2023
Q2 | $2.19M | Buy |
23,237
+275
| +1% | +$25.9K | 1.1% | 34 |
|
|
2023
Q1 | $1.9M | Sell |
22,962
-10,241
| -31% | -$847K | 1.13% | 32 |
|
|
2022
Q4 | $2.48M | Buy |
33,203
+1,085
| +3% | +$81K | 1.53% | 28 |
|
|
2022
Q3 | $2.65M | Buy |
32,118
+1,246
| +4% | +$103K | 1.69% | 24 |
|
|
2022
Q2 | $2.94M | Buy |
30,872
+466
| +2% | +$44.3K | 1.9% | 23 |
|
|
2022
Q1 | $3.58M | Buy |
30,406
+720
| +2% | +$84.7K | 1.92% | 21 |
|
|
2021
Q4 | $3.85M | Buy |
29,686
+654
| +2% | +$84.7K | 1.93% | 23 |
|
|
2021
Q3 | $3.29M | Buy |
29,032
+346
| +1% | +$39.2K | 1.92% | 25 |
|
|
2021
Q2 | $2.97M | Buy |
28,686
+682
| +2% | +$70.6K | 1.79% | 29 |
|
|
2021
Q1 | $2.34M | Buy |
28,004
+1,847
| +7% | +$154K | 1.55% | 27 |
|
|
2020
Q4 | $2.39M | Buy |
26,157
+422
| +2% | +$38.5K | 1.66% | 24 |
|
|
2020
Q3 | $2.05M | Buy |
25,735
+180
| +0.7% | +$14.4K | 1.58% | 25 |
|
|
2020
Q2 | $1.77M | Buy |
25,555
+2,860
| +13% | +$198K | 1.52% | 27 |
|
|
2020
Q1 | $1.43M | Sell |
22,695
-15,384
| -40% | -$967K | 2.06% | 22 |
|
|
2019
Q4 | $2.96M | Buy |
+38,079
| New | +$2.96M | 2.82% | 15 |
|